Ability of FDG-PET to detect all cancers in patients with familial adenomatous polyposis, and impact on clinical management
M. van Kouwen, J. Drenth, J. van Krieken, H. van Goor, P. Friederich, W. Oyen and F. NagengastArticles
EJNMMI
2006
270--274
Noninvasive monitoring of colonic carcinogenesis: feasibility of [(18)F]FDG-PET in the azoxymethane model
M. van Kouwen, P. Laverman, J. van Krieken, W. Oyen, F. Nagengast and J. DrenthArticles
NUCMB
2006
245--248
Bone SPECT reduces the number of unnecessary mandibular resections in patients with squamous cell carcinoma
E. Van Cann, W. Oyen, R. Koole and P. StoelingaArticles
OO
2006
409--414
Renal uptake of radiolabeled octreotide in human subjects is efficiently inhibited by succinylated gelatin
E. Vegt, J. Wetzels, F. Russel, R. Masereeuw, O. Boerman, J. van Eerd, F. Corstens and W. OyenArticles
JNM
2006
432--436
Synthesis and biological evaluation of potent alphavbeta3-integrin receptor antagonists
I. Dijkgraaf, J. Kruijtzer, C. Frielink, A. Soede, H. Hilbers, W. Oyen, F. Corstens, R. Liskamp and O. BoermanArticles
NUCMB
2006
953--961
Adequate evaluation of image registration in hybrid PET/CT
W. Vogel, J. van Dalen and W. OyenArticles
JNM
2006
1556; author reply 1557--1556; author reply 1558
Correction of an image size difference between positron emission tomography (PET) and computed tomography (CT) improves image fusion of dedicated PET and CT
W. Vogel, J. van Dalen, D. Schinagl, J. Kaanders, H. Huisman, F. Corstens and W. OyenArticles
NUCMC
2006
515--519
FDG-PET for imaging of non-osseous infection and inflammation
F. Vos, C. Bleeker-Rovers, F. Corstens, B. Kullberg and W. OyenArticles
QJNUCMEDMOLIMA
2006
121--130
Detection of pacemaker and lead infection with FDG-PET
F. Vos, C. Bleeker-Rovers, A. van Dijk and W. OyenArticles
EJNMMI
2006
1245
Development of 111In-labeled tumor-associated antigen peptides for monitoring dendritic-cell-based vaccination
P. Laverman, I. de Vries, N. Scharenborg, A. de Boer, M. Broekema, W. Oyen, C. Figdor, G. Adema and O. BoermanArticles
NUCMB
2006
453--458
Scintigraphic imaging of P-glycoprotein expression with a radiolabelled antibody
J. van Eerd, L. de Geus-Oei, W. Oyen, F. Corstens and O. BoermanArticles
EJNMMI
2006
1266--1272
Gelatin-based plasma expander effectively reduces renal uptake of 111In-octreotide in mice and rats
J. van Eerd, E. Vegt, J. Wetzels, F. Russel, R. Masereeuw, F. Corstens, W. Oyen and O. BoermanArticles
JNM
2006
528--533
Intravenously administered short interfering RNA accumulates in the kidney and selectively suppresses gene function in renal proximal tubules
F. van de Water, O. Boerman, A. Wouterse, J. Peters, F. Russel and R. MasereeuwArticles
Drug Metab Dispos
2006
1393--1397
M line-deficient titin causes cardiac lethality through impaired maturation of the sarcomere
S. Weinert, N. Bergmann, X. Luo, B. Erdmann and M. GotthardtArticles
JCELBIO
2006
559--570
FDG-PET in the clinically negative neck in oral squamous cell carcinoma
B. Wensing, W. Vogel, H. Marres, M. Merkx, E. Postema, W. Oyen and F. van den HoogenArticles
Laryngoscope
2006
809--813
FDG-PET for prediction of survival of patients with metastatic colorectal carcinoma
L. de Geus-Oei, B. Wiering, P. Krabbe, T. Ruers, C. Punt and W. OyenArticles
AOO
2006
1650--1655
[Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting
D. Wild, M. Béhé, A. Wicki, D. Storch, B. Waser, M. Gotthardt, B. Keil, G. Christofori, J. Reubi and H. MäckeArticles
JNM
2006
2025--2033
Effects of hyperoxygenation on FDG-uptake in head-and-neck cancer
L. de Geus-Oei, J. Kaanders, L. Pop, F. Corstens and W. OyenArticles
RTO
2006
51--56
18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results
L. de Geus-Oei, G. Pieters, J. Bonenkamp, A. Mudde, C. Bleeker-Rovers, F. Corstens and W. OyenArticles
JNM
2006
770--775
FDG-PET in colorectal cancer
L. de Geus-Oei, T. Ruers, C. Punt, J. Leer, F. Corstens and W. OyenArticles
CANI
2006
S71--S81